ReviewMaternal-fetal medicine (Wolters Kluwer Health, Inc.)2025
Postpartum Hemorrhage.
Review in Maternal-fetal medicine (Wolters Kluwer Health, Inc.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Global landscape of maternal hemorrhage mortality: a 40-year analysis based on GBD 2021 study.Archives of gynecology and obstetrics · 2026Article
- Improving Obstetric Safety in Postpartum Hemorrhage: Impact of Protocol-Based Conservative Management.Life (Basel, Switzerland) · 2026Review
- Rapid detection of fibrinolytic activation in postpartum hemorrhage and acute obstetric coagulopathy using a novel assay.Blood advances · 2026Article
- Innovative Approach for Rapid Control of Postpartum Hemorrhage With Abdominal Pressure.Maternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2026Article
- Congenital factor VII deficiency as a cause of postpartum hemorrhage: A case report.Case reports in women's health · 2026Article
- Global, Regional, and National Epidemiology of Postpartum Hemorrhage (1990-2021): A Statistical Analysis of Incidence, Mortality, and DALYs.Health science reports · 2026Article
- The differential role of anesthetic technique by etiology of postpartum hemorrhage: a dual-cohort analysis of emergency cesarean delivery and placenta accreta spectrum.Frontiers in medicine · 2026Article
- Transfusion risk assessment for cesarean delivery: a preoperative tool to guide blood utilization.Blood transfusion = Trasfusione del sangueArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obstetric hemorrhage is the leading cause of maternal death in childbirth; it is estimated that one woman dies every four minutes from postpartum hemorrhage (PPH). PPH is the cause of approximately one-quarter of maternal deaths worldwide and is thus a major public health issue of great importance. Despite modern advances in medicine, hemorrhage continues to lead the causes of pregnancy-related death in most countries, with increasing disparity between countries with highly developed and underdeveloped national healthcare systems. Most deaths caused by PPH are preventable. All involved in the care of pregnant women must be aware of the gravity of this problem, ways of identifying women at risk for severe hemorrhage at childbirth, strategies for preventing and ameliorating blood loss at delivery, and finally ways to deal with obstetric hemorrhage when it does occur. This article reviews the impact of obstetric hemorrhage, the controversy regarding definitions, diagnosis, epidemiology, pathophysiology, and management of obstetric hemorrhage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.